BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Aptose to Participate in Two Biotech Events in January 2022

  Aptose Biosciences Inc. today announced that the company will participate in two separate biotech events in January 2022: the H.C. Wainwright BIOCONNECT Virtual Conference and the 11th Annual LifeSci Partners Corporate Access Event.

  December 29, 2021

   · 

  1 min read
• Business

  SyMap Medical Ltd. Announces its Strategic Collaboration with Pythagoras Medical

  SyMap Medical Ltd (SyMap) announced its strategic collaboration with Pythagoras Medical.

  December 29, 2021

   · 

  2 min read
• Drug Development

  Bio-Thera Solutions Announces Initiation of Phase I Clinical Trials for BAT6026, a Monoclonal Antibody Targeting OX40

  Bio-Thera Solutions, Ltd. today announced that dosing has begun in Phase I clinical study to compare the pharmacokinetics and safety of BAT6026, an agonist monoclonal antibody targeting OX40 in cancer patient volunteers.

  December 29, 2021

   · 

  4 min read
• Business

  Universe Pharmaceuticals INC Announces Strategic Alliance with Jinggangshan University for Study on the Chemical Constituents of Certain Traditional Chinese Medicine

  Universe Pharmaceuticals INC Announces Strategic Alliance with Jinggangshan University for Study on the Chemical Constituents of Certain Traditional Chinese Medicine.

  December 29, 2021

   · 

  3 min read
• Drug Development

  Salarius Pharmaceuticals Achieves Dosing Milestone in Ongoing Phase 1/2 Sarcoma Trial

  Salarius Pharmaceuticals, Inc. today announced an important dosing milestone in the Phase 1/2 Sarcoma clinical trial evaluating seclidemstat as a treatment for Ewing sarcoma and other FET-rearranged sarcomas.

  December 29, 2021

   · 

  6 min read
• BioForest

  Adaptive Biotechnologies to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference

  Adaptive Biotechnologies Corporation today announced it will be participating in the upcoming 40th Annual J.P. Morgan Healthcare Conference.

  December 29, 2021

   · 

  1 min read
• Pharm Country

  Janssen Submits Biologics License Application to U.S. FDA Seeking Approval of Teclistamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

  The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval of teclistamab for the treatment of patients with relapsed or refractory (R/R) multiple myeloma.

  December 29, 2021

   · 

  7 min read
• /R E P E A T -- Atmofizer To Attend CES 2022 In Las Vegas/

  Atmofizer Technologies Inc. is pleased to announce that it will attend the 2022 Consumer Electronics Show.

  December 29, 2021

   · 

  6 min read
• Biotech Bay

  Guardant Health to Participate Virtually in the 40th Annual J.P. Morgan Healthcare Conference

  Guardant Health to Participate Virtually in the 40th Annual J.P. Morgan Healthcare Conference.

  December 29, 2021

   · 

  1 min read
• Genetown

  Amylyx Pharmaceuticals Announces FDA Acceptance and Priority Review of New Drug Application (NDA) for AMX0035 for the Treatment of ALS

  Amylyx Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review its New Drug Application (NDA) for AMX0035 (sodium phenylbutyrate (PB) and taurursodiol (TURSO; also known as ursodoxicoltaurine)) for the treatment of amyotrophic lateral sclerosis (ALS).

  December 29, 2021

   · 

  8 min read